Schizophrenia is the result of a combined dysfunction of genetic, biochemical and neurodevelopmental components that may be triggered by environmental factors. This cascade of events will most likely lead to disruption of cellular and tissue homeostasis, impairing the molecular pathways, which govern the cellular machinery throughout the body. Given the widespread nature of these effects, multiplex molecular approaches such as proteomics are required to provide new insights, as such methods can target hundreds of disease-relevant molecules, including those involved in the pathogenesis. In addition, by identifying specific proteins that are present at different steady-state levels in the disease state, proteomics can aid the discovery of molecular biomarker candidates.^[@bib1]^

Although our understanding of the molecular basis of schizophrenia has evolved recently, there are still many factors that do not connect or are still unknown. Thus, identification of these factors and increasing our understanding of their impact on the disease would be an important step forward. In addition, no factors emerging from molecular studies have been translated into clinical use for schizophrenia studies to date, despite the urgent need for both disease- and medication-related biomarker candidates. This is of particular importance owing to the fact that schizophrenia is an incurable disorder, which demands continuous healthcare, thus generating lifelong suffering for the patients and substantial expenses on the health-care systems. In the US, treatment and management of schizophrenia was estimated at a cost of 62 billion dollars per year, in the year 2000.^[@bib2]^

Although psychosocial interventions are available, disease management is mainly based on treatment with antipsychotic medications. However, \~40% of schizophrenia patients do not respond properly to these medications and \>60% end up abandoning treatment due to undesirable side effects.^[@bib3]^ Consequently, the intellectual and cognitive capacities of the patients may worsen, making them incapable of functioning adequately in society, thereby producing a further socioeconomic burden.

Consistent with our lack of understanding of disease pathophysiology, knowledge on the effects of medication on metabolism and other molecular pathways in the patients is scarce. With this in mind, we have employed a proteomic approach in an attempt to increase the understanding of the molecular pathways affected in response to currently used atypical antipsychotic medications. It was of particular interest to identify biomarker candidates associated with a positive response. The availability of such early-response biomarkers could eventually be used to help diminish the duration of poor response periods, thereby diminishing disease severity and improving the outcomes for the patients.

The cohort studied in this investigation consisted of 58 acutely ill patients who received the atypical antipsychotic drugs olanzapine (*n*=18), quetiapine (*n*=14) or risperidone (*n*=26) ([Table 1](#tbl1){ref-type="table"}). Blood samples were collected by intravenous puncture as previously described in the psychiatric Clinic of the University of Magdeburg (Germany).^[@bib4]^ Citrate plasma samples were collected at baseline (T0), when patients were acutely ill and either antipsychotic-naive (*n*=23) or antipsychotic-free for at least 6 weeks (*n*=35), and after 6 weeks when all the subjects had been treated as inpatients (T6). Patients with other medical conditions such as type 2 diabetes mellitus, hypertension, cardiovascular or autoimmune diseases were excluded. In line with previous studies,^[@bib5]^ the patients were separated into responders (*n*=36) and non-responders (*n*=22), with response defined as a 50% reduction of the corrected (subtraction of minimum scores representing 'no symptoms') total Positive and Negative Syndrome Scale (PANSS) scores. The percentage of responders was similar in the antipsychotic-naive (61%; 14/23) and antipsychotic-free (63%; 22/35) subgroups ([Table 1](#tbl1){ref-type="table"}).

Blood samples were immediately centrifuged for 10 min at 2,000×*g* and resulting supernatants divided in 250-μl aliquots, which were immediately frozen at −80 °C. Protein concentrations were determined by Bradford assay. Next, the plasma samples were depleted of 14 high-abundant proteins using the MARS-14 immunodepletion system (Agilent; Wokingham, UK)^[@bib6]^ as these tend to obscure lower abundance proteins in proteomic studies. Flow-through fractions containing mostly low abundant proteins were treated successively with 5 mM dithiothreitol (30 min, room temperature) and 10 mM iodoacetamide (30 min, 60 °C in the dark) to block reactive sulfhydryl groups on the proteins. The proteins in the samples were then enzymatically digested using trypsin (Promega, Heidelberg) at a trypsin:protein ratio of 1:50 for 16 h at 37 °C.

The peptides resulting from the trypsin digestion were analyzed using an Ultimate 3000 Rapid Separation Liquid Chromatography system (Dionex, Amsterdam, The Netherlands) coupled to an Orbitrap Elite mass spectrometer (Thermo Scientific, Bremen, Germany). For the chromatography stage, 1 μg of peptide mixture from each sample was preconcentrated on a 100-μm trapping column (Acclaim C18 PepMap100, 100 μm×2 cm, Thermo Scientific) at a flow rate of 20 μl/min in 0.1% trifluoroacetic acid. This was followed by separation on a 75-μm column (Acclaim C18 PepMap100, 75 μm×50 cm, Thermo Scientific) using a binary gradient of solvents A (0.1% formic acid) and B (0.1% formic acid in 84% acetonitrile) ranging from 3/97% A/B to 58/42% A/B over 160 min at a flow rate of 250 nl/min. In order to minimize carry-over effects from previous sample runs, a wash program with high organic content was used prior to each sample injection.^[@bib7]^

For the mass spectrometry stage, samples were measured in data dependent acquisition mode, survey scans were acquired in the Orbitrap at resolution 60,000 and the 10 most intense signals were fragmented in the ion trap using collision-induced dissociation (CID). The respective target values and maximum injection times were 10^6^ ions and 100 ms for the MS stage, and 10^4^ ions and 50 ms for the MS/MS stage. Precursor ions with charge states between +2 and +5 were selected for fragmentation, using a dynamic exclusion of 15 s.

The resulting raw data were processed using an in-house version of the MASCOT search engine for protein identification and MASCOT Distiller for label-free spectral counting quantification. The cut-off criteria were set at a minimum of 2 peptides for identification and at least 5 MS/MS spectra for quantification. Differences in protein expression between T6 and T0 samples for each patient were determined using Student\'s *t-*test (*P*\<0.05) with a false discovery rate set at 0.1. Differentially expressed proteins were classified according to their biological and molecular processes using the Human Protein Reference Database (<http://www.hprd.org>). For interpretation of the biological and biochemical significance of differentially expressed proteins, the UniProt identification codes of proteins with a T6/T0 ratio\>2:1 (*P*\>0.05) were uploaded into the Ingenuity Pathways Knowledgebase (IPKB). This software determines over-represented pathways by overlaying experimental protein data onto pre-existing biological pathway maps. The shotgun mass spectrometry profiling analysis resulted in identification of 18,227 peptides, corresponding to 985 proteins associated with 10 different biological processes ([Figure 1a](#fig1){ref-type="fig"}). Intriguingly, 25% of the proteins are of unknown function and are under investigation by our group.

Samples results were divided in four groups. These were T0 responders (T0-R), T6 responders (T6-R), T0 non-responders (T0-NR) and T6 non-responders (T6-NR), independent of the antipsychotic employed. The comparison T6-R/T0-R resulted in identification of 41 differentially expressed proteins, which ranged across seven biological processes ([Table 2](#tbl2){ref-type="table"}). The comparison T6-NR/T0-NR identified 58 differentially expressed proteins, which covered eight biological processes ([Table 3](#tbl3){ref-type="table"}). One of the proteins (coronin-2A) was increased in responders and decreased in non-responders. We evaluated the differential expression of coronin-2A by western blot as described previously^[@bib8]^ in two pools of the same samples analyzed by mass spectrometry to confirm this was not technically biased. The mass spectrometry finding was validated using a primary antibody against coronin-2A (Pierce, PA5--30206) ([Figure 1b](#fig1){ref-type="fig"}). The blotting membrane was stained with Ponceau Red and used as loading control.

In general, responders and non-responders showed similar effects on the same biochemical pathways after 6 weeks of antipsychotic treatment ([Figure 1c](#fig1){ref-type="fig"}). However, there were some differences as responders showed changes in almost twice the number of proteins involved in protein metabolism pathways, non-responders showed energy metabolism differences, which were not observed in the responders.

Potentially the most important finding of this study was that antipsychotic treatment led to opposite directional changes in some of the component proteins in responders and non-responders, as described for coronin-2A above. For example, the responders showed a 4.1 to 1 ratio of decreased to increased proteins in the pathway 'regulation of nucleic acids metabolism', and this ratio was 2.0 to 1 in the non-responders ([Figure 1c and d](#fig1){ref-type="fig"}). A similar scenario was observed for altered proteins associated with 'protein metabolism'. Although most of the protein components of this pathway showed a decrease in responders, all of the proteins of this same pathway were increased in non-responders.

Proteins regulating nucleic acids metabolism modulated by antipsychotics may be pivotal to processes such as DNA methylation and demethylation as well as chromatin remodeling, which may balance gene expression in response to antipsychotics.^[@bib9]^ The differences we observed here reinforce the notion that the success of antipsychotic medication may be dependent on individual genetic backgrounds. In this scenario, the absorption, transport, receptor binding, metabolism and excretion of antipsychotics will be distinct for each patient. This supports the concept of personalized medicine strategies using pharmacogenomic approaches as a means of maximizing the potential effects of medications.^[@bib10]^ In this study, antipsychotic treatment also modulated proteins associated with the 'metabolism of proteins' pathway oppositely in responders and non-responders. This is most likely related to protein turnover effects and may explain some of the above differences in protein expression levels in the two groups, as described in a previous study of antipsychotic treatment response (Lester *et al.* 2012).

The present results indicate that classifying responders and non-responders on the level of biochemical pathways rather than individual proteins may lead to a better understanding of the diverse effects of antipsychotics in schizophrenia patients. Investigation of individual proteins may not be as useful considering the diverse nature of human samples and the existence of redundant systems for the regulation of biochemical pathways in most biological systems. Nevertheless, several of these proteins such as coronin-2A are currently undergoing further analysis in our laboratory as potential antipsychotic treatment response biomarkers. Besides the added value to strategies of translational and personalized medicine, our results suggest new directions to be taken in the search for more effective treatments and the development of new medications for individuals suffering from schizophrenia.
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![(**a**) Biological processes represented by all 985 plasma proteins identified through the shotgun mass spectrometry profiling approach; (**b**) western blot validation of the mass spectrometry findings for coronin-2A, which showed increased levels in responders and decreased levels in non-responders; (**c**) Biological pathways affected by antipsychotics in responders (blue bars) and non-responders (red bars); (**d**) Percentage of proteins increased in responders (blue), decreased in responders (red), increased in non-responders (green) and decreased in non-responders (purple) in the same biological pathways shown in part (**c**). For (**c** and **d**) the *y* axis represents the percentage of differentially expressed proteins associated to those processes and a star indicates significant differences of the protein constituents (**c**) or directional changes (**d**) within a pathway.](npjschz201550-f1){#fig1}

###### Patients demographics and PANSS score before and after treatment

  *ID patient*   *T0 raw PANSS*   *T0 corrected PANSS*   *T6 raw PANSS*   *T6 corrected PANSS*   *Good response ⩾50% corrected PANSS total reduction*   *First episode patient*   *Drug naive*   *Illness duration \[years\]*   *Medication*   *Gender*   *Age*   *BMI*   *Smoking*                                                                                               
  -------------- ---------------- ---------------------- ---------------- ---------------------- ------------------------------------------------------ ------------------------- -------------- ------------------------------ -------------- ---------- ------- ------- ----------- ---- ---- ---- ------- ---------------- ----- ----- ---- ------------ --- ---- ------ ----- ---
  99             7                17                     37               61                     0                                                      10                        21             31                             7              11         29      50      0           4    13   17   0.45     Bad responder    Yes   Yes   0    Quetiapie    F  31   19.7    No    
  105            28               32                     63               123                    21                                                     25                        47             93                             33             32         64      141     26          25   48   99   −0.06    Bad responder    No    No    15   Quetiapie    M  47   21.8    Yes   
  129            22               29                     45               101                    15                                                     22                        29             66                             14             24         32      74      7           17   16   40   0.39     Bad responder    No    No         Risperidoe   F  49   23.9    Yes   
  133            17               34                     49               106                    10                                                     27                        33             70                             10             18         28      59      3           11   12   26   0.63     Good responder   Yes   No    0    Olanzapie    F  25   24.0    Yes   
  136            24               24                     46               104                    17                                                     17                        30             64                             15             11         26      55      8           4    10   22   0.66     Good responder   No    No         Risperidoe   F  44   27.4    No    
  140            25               26                     58               115                    18                                                     19                        42             79                             16             15         34      72      9           8    18   35   0.56     Good responder   No    No    7    Risperidoe   M  30   22.2    Yes   
  147            31               31                     55               126                    24                                                     24                        39             87                             12             24         39      82      5           17   23   45   0.48     Bad responder    Yes   Yes   0    Olanzapie    M  25   28.1    Yes   
  151            26               9                      40               79                     19                                                     2                         24             45                             8              8          19      38      1           1    3    5    0.89     Good responder   No    No    0    Olanzapie    F  45   30.5    Yes   
  156            17               16                     28               64                     10                                                     9                         12             31                             12             13         24      54      5           6    8    19   0.39     Bad responder    No    No    2    Risperidoe   M  42   32.9    Yes   
  162            20               16                     37               76                     13                                                     9                         21             43                             7              14         19      43      0           7    3    10   0.77     Good responder   Yes   Yes   0    Risperidoe   M  19   20.2    Yes   
  208            38               18                     35               109                    31                                                     11                        19             61                             12             9          20      44      5           2    4    11   0.82     Good responder   No    No    9    Olanzapie    M  28   25.3    Yes   
  247            25               25                     55               111                    18                                                     18                        39             75                             15             8          27      54      8           1    11   20   0.73     Good responder   No    No    7    Risperidoe   M  40   23.0    Yes   
  249            22               41                     41               107                    15                                                     34                        25             74                             17             31         37      90      10          24   21   55   0.26     Bad responder    No    No    19   Risperidoe   M  44   17.7    Yes   
  260            21               11                     31               76                     14                                                     4                         15             33                             8              24         24      59      1           17   8    26   0.21     Bad responder    No    No    1    Olanzapie    M  22   27.5    No    
  277            26               12                     38               83                     19                                                     5                         22             46                             9              7          21      42      2           0    5    7    0.85     Good responder   Yes   Yes   0    Risperidoe   F  20   22.2    No    
  278            37               29                     58               137                    30                                                     22                        42             94                             13             22         30      71      6           15   14   35   0.63     Good responder   No    No    9    Risperidoe   M  31   22.8    Yes   
  331            31               9                      41               92                     24                                                     2                         25             51                             15             8          31      61      8           1    15   24   0.53     Good responder   No    No    23   Olanzapie    F  39   29.8    Yes   
  332            23               29                     39               95                     16                                                     22                        23             61                             16             24         31      75      9           17   15   41   0.33     Bad responder    Yes   Yes   0    Risperidoe   F  26   22.1    No    
  363            27               25                     41               100                    20                                                     18                        25             63                             10             16         23      52      3           9    7    19   0.70     Good responder   Yes   Yes   0    Risperidoe   M  25   20.1    Yes   
  366            28               16                     40               93                     21                                                     9                         24             54                             9              10         21      43      2           3    5    10   0.81     Good responder   Yes   Yes   0    Olanzapie    M  34   27.7    No    
  368            34               20                     61               132                    27                                                     13                        45             85                             17             20         47      91      10          13   31   54   0.36     Bad responder    Yes   Yes   0    Risperidoe   M  16   26.5    Yes   
  370            26               9                      39               81                     19                                                     2                         23             44                             9              15         27      54      2           8    11   21   0.52     Good responder   Yes   Yes   0    Risperidoe   M  31   24.4    No    
  371            35               14                     43               104                    28                                                     7                         27             62                             8              7          20      38      1           0    4    5    0.92     Good responder   No    No    6    Risperidoe   F  48   37.2    No    
  375            18               30                     50               101                    11                                                     23                        34             68                             21             27         42      97      14          20   26   60   0.12     Bad responder    Yes   Yes   0    Quetiapie    M  23   22.0    Yes   
  391            25               11                     51               97                     18                                                     4                         35             57                             11             9          22      45      4           2    6    12   0.79     Good responder   No    No    32   Quetiapie    F  55   29.8    No    
  400            19               27                     54               108                    12                                                     20                        38             70                             7              11         20      41      0           4    4    8    0.89     Good responder   No    No         Quetiapie    F  32   22.7    No    
  404            29               10                     40               97                     22                                                     3                         24             49                             7              7          20      40      0           0    4    4    0.92     Good responder   No    No    6    Olanzapie    M  45   26.4    Yes   
  408            15               13                     52               87                     8                                                      6                         36             50                             15             19         41      82      8           12   25   45   0.10     Bad responder    No    No    2    Quetiapie    F  27   22.2    Yes   
  410            12               26                     47               91                     5                                                      19                        31             55                             20             23         48      98      13          16   32   61   −0.11    Bad responder    No    No         Olanzapie    F  50   24.1    Yes   
  422            28               41                     45               121                    21                                                     34                        29             84                             7              9          24      43      0           2    8    10   0.88     Good responder   No    No    11   Risperidoe   M  34   23.6    Yes   
  426            26               23                     46               105                    19                                                     16                        30             65                             12             10         22      47      5           3    6    14   0.78     Good responder   No    No    7    Risperidoe   M  30   21.5    Yes   
  428            20               10                     60               94                     13                                                     3                         44             60                             19             12         50      89      12          5    34   51   0.15     Bad responder    Yes   Yes   0    Quetiapie    F  38   32.9    Yes   
  431            24               26                     42               95                     17                                                     19                        26             62                             12             14         26      55      5           7    10   22   0.65     Good responder   Yes   Yes   0    Olanzapie    M  29   21.1    Yes   
  440            33               12                     45               104                    26                                                     5                         29             60                             13             11         33      65      6           4    17   27   0.55     Good responder   No    No    32   Olanzapie    F  59   35.0    No    
  452            14               20                     36               80                     7                                                      13                        20             40                             17             9          26      65      10          2    10   22   0.45     Bad responder    No    No    15   Risperidoe   M  36   22.4    No    
  454            22               16                     48               94                     15                                                     9                         32             56                             7              7          16      33      0           0    0    0    1.00     Good responder   Yes   Yes   0    Risperidoe   M  34   22.2    Yes   
  464            25               18                     37               94                     18                                                     11                        21             50                             8              14         25      50      1           7    9    17   0.66     Good responder   Yes   Yes   0    Risperidoe   F  66   31.6    Yes   
  468            19               18                     48               88                     12                                                     11                        32             55                             9              18         24      54      2           11   8    21   0.62     Good responder   No    No    1    Risperidoe   M  35   18.3    No    
  474            28               14                     51               99                     21                                                     7                         35             63                             32             21         42      105     25          14   26   65   −0.03    Bad responder    No    No    11   Quetiapie    M  32   25.0    Yes   
  476            17               17                     37               76                     10                                                     10                        21             41                             14             11         32      64      7           4    16   27   0.34     Bad responder    No    No    7    Quetiapie    M  25   22.0    Yes   
  479            24               14                     44               91                     17                                                     7                         28             52                             13             9          26      52      6           2    10   18   0.65     Good responder   Yes   Yes   0    Olanzapie    F  53   20.1    Yes   
  487            37               7                      62               115                    30                                                     0                         46             76                             13             17         32      70      6           10   16   32   0.58     Good responder   Yes   Yes   0    Quetiapie    M  39   21.1    Yes   
  493            28               29                     51               116                    21                                                     22                        35             78                             15             21         29      68      8           14   13   35   0.55     Good responder   Yes   Yes   0    Risperidoe   M  50   19.7    Yes   
  520            16               24                     38               90                     9                                                      17                        22             48                             9              11         25      49      2           4    9    15   0.69     Good responder   No    No    0    Quetiapie    F  31   28.7    Yes   
  521            27               17                     50               102                    20                                                     10                        34             64                             10             9          21      43      3           2    5    10   0.84     Good responder   No    No    10   Olanzapie    M  32   30.8    No    
  522            17               7                      40               67                     10                                                     0                         24             34                             17             9          27      57      10          2    11   23   0.32     Bad responder    Yes   Yes   0    Quetiapie    M  26   21.0    Yes   
  524            21               13                     40               79                     14                                                     6                         24             44                             12             14         29      58      5           7    13   25   0.43     Bad responder    Yes   Yes   0    Olanzapie    F  36   22.0    Yes   
  526            26               38                     71               138                    19                                                     31                        55             105                            16             29         39      87      9           22   23   54   0.49     Bad responder    Yes   Yes   0    Olanzapie    M  23   22.2    No    
  539            24               27                     58               112                    17                                                     20                        42             79                             21             16         49      94      14          9    33   56   0.29     Bad responder    No    No    3    Quetiapie    M  28   23.2    Yes   
  541            16               7                      30               53                     9                                                      0                         14             23                             13             7          25      56      6           0    9    15   0.35     Bad responder    No    No    34   Risperidoe   M  53   24.8    Yes   
  545            28               12                     35               84                     21                                                     5                         19             45                             15             7          23      55      8           0    7    15   0.67     Good responder   No    No    0    Olanzapie    F  50   28.6    Yes   
  568            21               30                     43               100                    14                                                     23                        27             64                             16             26         28      73      9           19   12   40   0.38     Bad responder    No    No    10   Risperidoe   F  56   29.1    No    
  570            26               12                     45               89                     19                                                     5                         29             53                             11             12         30      56      4           5    14   23   0.57     Good responder   No    No    3    Risperidoe   M  36   20.4    Yes   
  572            16               7                      25               51                     9                                                      0                         9              18                             7              7          17      34      0           0    1    1    0.94     Good responder   Yes   Yes   0    Quetiapie    F  36   21.9    Yes   
  579            14               18                     34               75                     7                                                      11                        18             36                             11             7          21      42      4           0    5    9    0.75     Good responder   Yes   Yes   0    Olanzapie    F  36   30.3    Yes   
  592            38               25                     43               122                    31                                                     18                        27             76                             15             7          41      68      8           0    25   33   0.57     Good responder   No    No    14   Olanzapie    M  30   31.1    No    
  663            23               11                     22               59                     16                                                     4                         6              26                             10             7          18      38      3           0    2    5    0.81     Good responder   No    No    21   Risperidoe   M  51   30.4    No    
  800            16               15                     30               65                     9                                                      8                         14             31                             11             8          18      40      4           1    2    7    0.77     Good responder   No    No    15   Risperidoe   M  58   20.6    No    

###### Differentially expressed proteins in *responders* before and after 6 weeks of antipsychotic treatment

  *Entry*    *Entry name*   *Gene name*  *Score*   *Mass*    *Resp T0×T6*    *Reg*  *StDev*   *Number of peptides*                            *Description*                                  *Biological process*                *Molecular class*                       *Molecular function*
  --------- -------------- ------------- --------- --------- -------------- ------- --------- ---------------------- ---------------------------------------------------------------- ---------------------------------- ---------------------------------- ----------------------------------------------
  Q92828     COR2A_HUMAN     *CORO2A*    35        60,239    0.12            Down   6.913     2                                                 Coronin-2A                             Cell communication and signaling             Unclassified                      Molecular function unknown
  O00622     CYR61_HUMAN      *CYR61*    41        44,165    0.03            Down   1.779     2                                               Protein CYR61                            Cell communication and signaling     Extracellular matrix protein     Extracellular matrix structural constituent
  Q5THR3     EFCB6_HUMAN     *EFCAB6*    35        174,702   3.57             Up    7.015     2                            EF-hand calcium-binding domain-containing protein 6         Cell communication and signaling       Calcium binding protein                    Calcium ion binding
  O94887     FARP2_HUMAN      *FARP2*    33        120,725   11.93            Up    3.329     2                          FERM, RhoGEF and pleckstrin domain-containing protein 2       Cell communication and signaling         Cytoskeletal protein            Structural constituent of cytoskeleton
  P78527     PRKDC_HUMAN      *PRKDC*    40        473,749   41.97            Up    1.948     2                               DNA-dependent protein kinase catalytic subunit           Cell communication and signaling       Serine/threonine kinase          Protein serine/threonine kinase activity
  Q15036     SNX17_HUMAN      *SNX17*    44        53,153    0.05            Down   3.201     4                                              Sorting nexin-17                          Cell communication and signaling           Adapter molecule           Receptor signaling complex scaffold activity
  O43294     TGFI1_HUMAN     *TGFB1I1*   39        51,321    0.31            Down   1.962     2                       Transforming growth factor beta-1-induced transcript 1 protein   Cell communication and signaling   Transcription regulatory protein         Transcription regulator activity
  Q9UPZ6     THS7A_HUMAN     *THSD7A*    30        192,854   0.03            Down   1.223     2                             Thrombospondin type-1 domain-containing protein 7A         Cell communication and signaling             Unclassified                      Molecular function unknown
  Q6F5E8     LR16C_HUMAN      *RLTPR*    39        156,133   20.44            Up    1.954     2                                 Leucine-rich repeat-containing protein 16C             Cell communication and signaling             Unclassified                      Molecular function unknown
  P00740      FA9_HUMAN        *F9*      154       53,114    0.36            Down   6.308     2                                           Coagulation factor IX                               Protein metabolism                 Coagulation factor                  Extracellular matrix binding
  P34931     HS71L_HUMAN     *HSPA1L*    45        70,730    0.45            Down   2.631     4                                      Heat shock 70 kDa protein 1-like                         Protein metabolism                 Heat shock protein                  Heat shock protein activity
  Q06033     ITIH3_HUMAN      *ITIH3*    299       100,072   1.52             Up    1.254     5                                Inter-alpha-trypsin inhibitor heavy chain H3                   Protein metabolism                 Protease inhibitor                  Protease inhibitor activity
  P09001      RM03_HUMAN      *MRPL3*    28        38,893    0.27            Down   1.813     2                                  39S ribosomal protein L3, mitochondrial                      Protein metabolism                 Ribosomal subunit                Structural constituent of ribosome
  P01011      AACT_HUMAN    *SERPINA3*   1317      47,792    1.48             Up    1.282     34                                         Alpha-1-antichymotrypsin                             Protein metabolism                 Protease inhibitor                  Protease inhibitor activity
  A1L167     YE019_HUMAN     *UBE2QL1*   71        18,440    0.06            Down   4.273     2                              Ubiquitin-conjugating enzyme E2Q-like protein 1                  Protein metabolism                    Unclassified                      Molecular function unknown
  Q9UHC1      MLH3_HUMAN      *MLH3*     28        166,060   0.05            Down   2.706     2                                      DNA mismatch repair protein Mlh3                      Reg. nucleic acid metab               DNA repair protein                        Protein binding
  O75592     MYCB2_HUMAN     *MYCBP2*    35        517,856   6.52             Up    5.641     2                                Probable E3 ubiquitin-protein ligase MYCBP2                 Reg. nucleic acid metab        Transcription regulatory protein         Transcription regulator activity
  Q8IZQ8      MYCD_HUMAN      *MYOCD*    34        102,561   0.43            Down   1.59      2                                                 Myocardin                                  Reg. nucleic acid metab              Transcription factor                Transcription factor activity
  O15350      P73_HUMAN       *TP73*     21        70,206    0.03            Down   1.951     2                                             Tumor protein p73                              Reg. nucleic acid metab              Transcription factor                Transcription factor activity
  Q9UL58     ZN215_HUMAN     *ZNF215*    40        60,922    0.11            Down   5.344     2                                          Zinc finger protein 215                           Reg. nucleic acid metab              DNA binding protein                          DNA binding
  Q2M3G0     ABCB5_HUMAN      *ABCB5*    31        90,173    64.78            Up    1.559     2                                 ATP-binding cassette sub-family B member 5                        Transport                  Integral membrane protein                   Transporter activity
  Q86UQ4     ABCAD_HUMAN     *ABCA13*    70        580,604   12.73            Up    5.368     2                                ATP-binding cassette sub-family A member 13                        Transport                   Transport/cargo protein                    Transporter activity
  P02768      ALBU_HUMAN       *ALB*     123       71,317    0.04            Down   1.8       6                                               Serum albumin                                       Transport                   Transport/cargo protein                    Transporter activity
  P06727     APOA4_HUMAN      *APOA4*    1502      45,371    0.51            Down   1.061     7                                            Apolipoprotein A-IV                                    Transport                   Transport/cargo protein                    Transporter activity
  P21796     VDAC1_HUMAN      *VDAC1*    26        30,868    26.82            Up    1.167     2                            Voltage-dependent anion-selective channel protein 1                    Transport                    Voltage-gated channel              Voltage-gated ion channel activity
  Q9BXS0     COPA1_HUMAN     *COL25A1*   28        65,145    0.06            Down   2.02      2                                        Collagen alpha-1(XXV) chain                       Cell growth and maintenance        Extracellular matrix protein     Extracellular matrix structural constituent
  Q16610      ECM1_HUMAN      *ECM1*     435       62,232    2.43             Up    6.347     2                                       Extracellular matrix protein 1                     Cell growth and maintenance        Extracellular matrix protein     Extracellular matrix structural constituent
  Q92556     ELMO1_HUMAN      *ELMO1*    46        84,517    0.13            Down   7.738     5                                   Engulfment and cell motility protein 1                 Cell growth and maintenance               Motor protein                            Motor activity
  P20929      NEBU_HUMAN       *NEB*     85        775,419   0.08            Down   7.593     6                                                  Nebulin                                 Cell growth and maintenance            Cytoskeletal protein            Structural constituent of cytoskeleton
  P23258      TBG1_HUMAN      *TUBG1*    27        51,480    0.46            Down   2.748     2                                           Tubulin gamma-1 chain                          Cell growth and maintenance            Cytoskeletal protein            Structural constituent of cytoskeleton
  O43866      CD5L_HUMAN      *CD5L*     201       39,603    3.03             Up    5.29      2                                              CD5 antigen-like                                  Immune response                  Secreted polypeptide              Defense/immunity protein activity
  Q5JU67     CI117_HUMAN    *C9orf117*   47        60,667    0.02            Down   1.229     2                                      Uncharacterized protein C9orf117                              Unknown                          Unclassified                      Molecular function unknown
  Q8IV32     CCD71_HUMAN     *CCDC71*    26        49,759    32.45            Up    4.607     2                                  Coiled-coil domain-containing protein 71                          Unknown                          Unclassified                      Molecular function unknown
  Q96AQ1     CC74A_HUMAN     *CCDC74A*   31        41,808    12.33            Up    1.079     2                                 Coiled-coil domain-containing protein 74A                          Unknown                          Unclassified                      Molecular function unknown
  Q6IPU0     CENPP_HUMAN      *CENPP*    38        33,429    20.20            Up    1.001     2                                            Centromere protein P                                    Unknown                          Unclassified                      Molecular function unknown
  Q6P4F2      ADXL_HUMAN      *FDX1L*    22        19,737    2.01             Up    1.341     2                                  Adrenodoxin-like protein, mitochondrial                           Unknown                          Unclassified                      Molecular function unknown
  Q6ZVN6     YO003_HUMAN      *HSD47*    60        33,173    0.29            Down   1.027     3                                       Uncharacterized protein HSD47                                Unknown                          Unclassified                      Molecular function unknown
  Q8N485      LIX1_HUMAN      *LIX1*     58        32,213    0.23            Down   2.73      5                                     Protein limb expression 1 homolog                              Unknown                          Unclassified                      Molecular function unknown
  Q969T7     5NT3L_HUMAN     *NT5C3B*    40        33,893    9.21             Up    1.238     3                           7-methylguanosine phosphate-specific 5\'-nucleotidase                    Unknown                          Unclassified                      Molecular function unknown
  O15018     PDZD2_HUMAN      *PDZD2*    29        303,964   25.23            Up    4.449     2                                      PDZ domain-containing protein 2                               Unknown                          Unclassified                      Molecular function unknown
  Q7Z6W1     TMCO2_HUMAN      *TMCO2*    22        20,287    2.59             Up    1.144     2                         Transmembrane and coiled-coil domain-containing protein 2                  Unknown                   Integral membrane protein                Molecular function unknown

###### Differentially expressed proteins in *non-responders* before and after 6 weeks of antipsychotic treatment

  *Entry*    *Entry name*   *Gene name*  *Score*   *Mass*      *Non Resp T0×T6*    *Reg*  *StDev*   *Number of peptides*                                 *Description*                                      *Biological process*                *Molecular class*                       *Molecular function*
  --------- -------------- ------------- --------- ----------- ------------------ ------- --------- ---------------------- ------------------------------------------------------------------------- ---------------------------------- ---------------------------------- ----------------------------------------------
  P10645      CMGA_HUMAN      *CHGA*     31        50,829      0.02                Down   1.972     3                                                   Chromogranin-A                                Cell communication and signaling         Secreted polypeptide              Defense/immunity protein activity
  Q92828     COR2A_HUMAN     *CORO2A*    35        60,239      9.12                 Up    1.259     2                                                     Coronin-2A                                  Cell communication and signaling             Unclassified                      Molecular function unknown
  O00622     CYR61_HUMAN      *CYR61*    41        44,165      0.42                Down   1.137     2                                                    Protein CYR61                                Cell communication and signaling     Extracellular matrix protein     Extracellular matrix structural constituent
  Q5THR3     EFCB6_HUMAN     *EFCAB6*    35        174,702     0.01                Down   5.227     2                                 EF-hand calcium-binding domain-containing protein 6             Cell communication and signaling       Calcium binding protein                    Calcium ion binding
  O94887     FARP2_HUMAN      *FARP2*    33        120,725     4.14                 Up    1.445     2                               FERM, RhoGEF and pleckstrin domain-containing protein 2           Cell communication and signaling         Cytoskeletal protein            Structural constituent of cytoskeleton
  Q8WXI7     MUC16_HUMAN      *MUC16*    29        2,359,682   0.04                Down   8.085     3                                                      Mucin-16                                   Cell communication and signaling      Integral membrane protein                Molecular function unknown
  Q8NH42     OR4KD_HUMAN     *OR4K13*    33        34,751      0.26                Down   4.954     3                                               Olfactory receptor 4K13                           Cell communication and signaling      G-protein coupled receptor          G-protein coupled receptor activity
  P51817      PRKX_HUMAN      *PRKX*     45        41,041      9.97                 Up    1.351     4                                cAMP-dependent protein kinase catalytic subunit PRKX             Cell communication and signaling       Serine/threonine kinase          Protein serine/threonine kinase activity
  Q6ZNA4     RN111_HUMAN     *RNF111*    59        110,119     18.82                Up    1.665     4                                         E3 ubiquitin-protein ligase Arkadia                     Cell communication and signaling             Unclassified                      Molecular function unknown
  Q16181     SEPT7_HUMAN    *SEPT07\_*   29        50,933      4.12                 Up    5.889     2                                                      Septin-7                                   Cell communication and signaling      Cell cycle control protein                    Protein binding
  Q15036     SNX17_HUMAN      *SNX17*    44        53,153      10.79                Up    1.184     3                                                  Sorting nexin-17                               Cell communication and signaling           Adapter molecule           Receptor signaling complex scaffold activity
  Q8IWB6     TEX14_HUMAN      *TEX14*    27        169,107     5.62                 Up    1.288     2                                   Inactive serine/threonine-protein kinase TEX14                Cell communication and signaling       Dual specificity kinase         Protein threonine/tyrosine kinase activity
  O43294     TGFI1_HUMAN     *TGFB1I1*   39        51,321      0.01                Down   4.21      2                           Transforming growth factor beta-1-induced transcript 1 protein        Cell communication and signaling   Transcription regulatory protein         Transcription regulator activity
  P30291      WEE1_HUMAN      *WEE1*     51        72,237      0.12                Down   3.019     4                                              Wee1-like protein kinase                           Cell communication and signaling       Dual specificity kinase         Protein threonine/tyrosine kinase activity
  Q9UPZ6     THS7A_HUMAN     *THSD7A*    30        192,854     0.01                Down   1.223     2                                 Thrombospondin type-1 domain-containing protein 7A              Cell communication and signaling             Unclassified                      Molecular function unknown
  Q9UHC1      MLH3_HUMAN      *MLH3*     28        166,060     0.01                Down   1.087     2                                          DNA mismatch repair protein Mlh3                           Reg. nucleic acid metab               DNA repair protein                        Protein binding
  Q9UGN5     PARP2_HUMAN      *PARP2*    28        66,734      6.29                 Up    1.04      2                                          Poly \[ADP-ribose\] polymerase 2                           Reg. nucleic acid metab              DNA binding protein                       Catalytic activity
  Q7L014     DDX46_HUMAN      *DDX46*    117       117,803     8.70                 Up    4.669     11                                     Probable ATP-dependent RNA helicase DDX46                      Reg. nucleic acid metab                  RNA helicase                          Helicase activity
  P26358     DNMT1_HUMAN      *DNMT1*    30        185,388     0.07                Down   1.08      2                                        DNA (cytosine-5)-methyltransferase 1                         Reg. nucleic acid metab             DNA methyltransferase                DNA methyltransferase activity
  Q8IZQ8      MYCD_HUMAN      *MYOCD*    34        102,561     9.73                 Up    2.619     2                                                      Myocardin                                      Reg. nucleic acid metab              Transcription factor                Transcription factor activity
  Q15366     PCBP2_HUMAN      *PCBP2*    17        38,955      0.01                Down   1.318     2                                             Poly(rC)-binding protein 2                              Reg. nucleic acid metab              RNA binding protein                          RNA binding
  Q5T200     ZC3HD_HUMAN     *ZC3H13*    33        197,203     0.02                Down   2.653     3                                    Zinc finger CCCH domain-containing protein 13                    Reg. nucleic acid metab        Transcription regulatory protein         Transcription regulator activity
  Q86UP3     ZFHX4_HUMAN      *ZFHX4*    35        398,157     7.38                 Up    7.307     2                                           Zinc finger homeobox protein 4                            Reg. nucleic acid metab              Transcription factor                Transcription factor activity
  Q9UL58     ZN215_HUMAN     *ZNF215*    40        60,922      0.02                Down   9.007     2                                               Zinc finger protein 215                               Reg. nucleic acid metab              DNA binding protein                          DNA binding
  Q86UQ4     ABCAD_HUMAN     *ABCA13*    70        580,604     0.05                Down   1.619     2                                     ATP-binding cassette sub-family A member 13                            Transport                   Transport/cargo protein                    Transporter activity
  P02768      ALBU_HUMAN       *ALB*     123       71,317      0.61                Down   4.848     6                                                    Serum albumin                                           Transport                   Transport/cargo protein                    Transporter activity
  P06727     APOA4_HUMAN      *APOA4*    1,502     45,371      0.56                Down   1.078     7                                                 Apolipoprotein A-IV                                        Transport                   Transport/cargo protein                    Transporter activity
  P04114      APOB_HUMAN      *APOB*     1,709     516,666     1.46                 Up    1.306     17                                               Apolipoprotein B-100                                        Transport                   Transport/cargo protein                    Transporter activity
  Q13439     GOGA4_HUMAN     *GOLGA4*    176       261,892     44.57                Up    1.39      15                                           Golgin sub-family A member 4                                    Transport                   Transport/cargo protein                    Transporter activity
  Q9UDX3     S14L4_HUMAN     *SEC14L4*   67        47,070      13.48                Up    1.447     3                                                SEC14-like protein 4                                        Transport                   Transport/cargo protein                    Transporter activity
  O14994      SYN3_HUMAN      *SYN3*     34        63,491      0.03                Down   1.434     2                                                     Synapsin-3                                             Transport                   Transport/cargo protein                    Transporter activity
  P21796     VDAC1_HUMAN      *VDAC1*    26        30,868      8.81                 Up    6.002     2                                 Voltage-dependent anion-selective channel protein 1                        Transport                    Voltage-gated channel              Voltage-gated ion channel activity
  Q96AW1      ECOP_HUMAN      *VOPP1*    32        19,839      2.46                 Up    1.841     2                              Vesicular, overexpressed in cancer, prosurvival protein 1            Cell growth and maintenance      Transcription regulatory protein         Transcription regulator activity
  Q16610      ECM1_HUMAN      *ECM1*     435       62,232      0.31                Down   5.743     2                                           Extracellular matrix protein 1                          Cell growth and maintenance        Extracellular matrix protein     Extracellular matrix structural constituent
  Q9P2E2     KIF17_HUMAN      *KIF17*    31        115,784     0.01                Down   1.028     2                                             Kinesin-like protein KIF17                            Cell growth and maintenance               Motor protein                            Motor activity
  Q9Y496     KIF3A_HUMAN      *KIF3A*    27        80,687      0.01                Down   1.08      2                                             Kinesin-like protein KIF3A                            Cell growth and maintenance               Motor protein                            Motor activity
  Q14764      MVP_HUMAN        *MVP*     36        99,551      7.09                 Up    3.151     4                                                 Major vault protein                               Cell growth and maintenance          Transport/cargo protein           Nucleocytoplasmic transporter activity
  Q00872     MYPC1_HUMAN     *MYBPC1*    35        129,240     0.01                Down   1.213     2                                         Myosin-binding protein C, slow-type                       Cell growth and maintenance             Structural protein                  Structural molecule activity
  P23258      TBG1_HUMAN      *TUBG1*    27        51,480      0.02                Down   1.934     2                                                Tubulin gamma-1 chain                              Cell growth and maintenance            Cytoskeletal protein            Structural constituent of cytoskeleton
  P02743      SAMP_HUMAN      *APCS*     2577      25,485      1.45                 Up    9.908     9                                              Serum amyloid P-component                                 Protein metabolism                Secreted polypeptide                           Binding
  O76031      CLPX_HUMAN      *CLPX*     41        69,922      25.86                Up    2.463     3                       ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial          Protein metabolism                      Protease                            Peptidase activity
  P00740      FA9_HUMAN        *F9*      154       53,114      3.06                 Up    3.201     2                                                Coagulation factor IX                                   Protein metabolism                 Coagulation factor                  Extracellular matrix binding
  P07225      PROS_HUMAN      *PROS1*    56        77,127      2.30                 Up    1.065     2                                            Vitamin K-dependent protein S                               Protein metabolism                 Coagulation factor                  Protease inhibitor activity
  A1L167     YE019_HUMAN     *UBE2QL1*   71        18,440      6.16                 Up    2.05      2                                   Ubiquitin-conjugating enzyme E2Q-like protein 1                      Protein metabolism                    Unclassified                      Molecular function unknown
  P06681      CO2_HUMAN        *C2*      995       84,583      1.57                 Up    1.269     7                                                    Complement C2                                        Immune response                   Complement protein                      Complement activity
  O14607      UTY_HUMAN        *UTY*     36        151,563     6.28                 Up    3.639     4                                               Histone demethylase UTY                                   Immune response                      Unclassified                      Molecular function unknown
  Q8WZ42     TITIN_HUMAN       *TTN*     44        3,843,119   4.82                 Up    1.558     3                                                        Titin                                           Energy Metabolism                  Structural protein                  Structural molecule activity
  Q2LD37     K1109_HUMAN    *KIAA1109*   25        559,165     0.01                Down   1.46      2                                          Uncharacterized protein KIAA1109                              Energy Metabolism                     Unclassified                      Molecular function unknown
  Q5JU67     CI117_HUMAN    *C9orf117*   47        60,667      29.92                Up    5.906     2                                          Uncharacterized protein C9orf117                                   Unknown                          Unclassified                      Molecular function unknown
  Q8IV32     CCD71_HUMAN     *CCDC71*    26        49,759      0.02                Down   1.543     2                                      Coiled-coil domain-containing protein 71                               Unknown                          Unclassified                      Molecular function unknown
  Q008S8      LFDH_HUMAN      *ECT2L*    39        105,782     0.33                Down   2.308     3                                Epithelial cell-transforming sequence 2 oncogene-like                        Unknown                          Unclassified                      Molecular function unknown
  Q6P4F2      ADXL_HUMAN      *FDX1L*    22        19,737      5.58                 Up    1.218     2                                       Adrenodoxin-like protein, mitochondrial                               Unknown                          Unclassified                      Molecular function unknown
  A6NMB9     FIGL2_HUMAN     *FIGNL2*    25        67,189      0.02                Down   1.825     2                                          Putative fidgetin-like protein 2                                   Unknown                          Unclassified                      Molecular function unknown
  Q8WTR4     GDPD5_HUMAN      *GDPD5*    24        69,112      15.84                Up    2.584     2                         Glycerophosphodiester phosphodiesterase domain-containing protein 5                 Unknown                          Unclassified                      Molecular function unknown
  Q969T7     5NT3L_HUMAN     *NT5C3B*    40        33,893      26.80                Up    2.534     3                                7-methylguanosine phosphate-specific 5\'-nucleotidase                        Unknown                          Unclassified                      Molecular function unknown
  Q68D10      SPT2_HUMAN     *SPTY2D1*   25        75,614      0.09                Down   3.268     2                                                Protein SPT2 homolog                                         Unknown                          Unclassified                      Molecular function unknown
  Q7Z6W1     TMCO2_HUMAN      *TMCO2*    22        20,287      6.46                 Up    1.541     2                              Transmembrane and coiled-coil domain-containing protein 2                      Unknown                   Integral membrane protein                Molecular function unknown
  Q9BZH6     BRWD2_HUMAN      *WDR11*    118       138,423     1.72                 Up    3.745     7                                           WD repeat-containing protein 11                                   Unknown                          Unclassified                      Molecular function unknown
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